Therapy With Atorvastatin Versus Rosuvastatin Reduces Urinary Podocytes, Podocyte-Associated Molecules, and Proximal Tubule Dysfunction Biomarkers in Patients With Type 2 Diabetes Mellitus: A Pilot Study
Renal Failure - United States
doi 10.1080/0886022x.2016.1254657
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2016
Authors
Publisher
Informa UK Limited